Rebecca Taub, President, R&D, and CMO at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 1,296 shares at $335.24 ($434K) on 2025-01-24, disclosed to the SEC on 2025-01-27.
Open-market sale of $434k MDGL by President, R&D, and CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $335.24 | 648 | $217K | 50.0% |
| 2 | $335.24 | 648 | $217K | 50.0% |
| Total | $335.24 avg | 1,296 | $434K | 100% |
| Filing → |
| MDGL | SELL | 2026-01-20 | $1.1M | — | Filing → |
| MDGL | SELL | 2026-01-13 | $18.9M | — | Filing → |
| MDGL | SELL | 2026-01-13 | $242K | — | Filing → |